Gaelle Auguste demonstrated that treatment with the BRD4 inhibitor JQ1 partially reverses the transcript levels of molecular markers of cardiac hypertrophy and cardiac dysfunction in LMNA-deficient cardiomyocytes. Here, BRD4 is linked to cardiac hypertrophy.